ADAG Adagene Inc.
$3.40▲ +2.72%
Healthcare
Other
After hours
$3.34▼ -1.76%
Sep 11, 7:30 PM ET
Volume 258.6K
Avg Volume (10D) 165.5K
Key Metrics & Fundamentals
Market Cap
$228.29M
P/E Ratio
–
Div Yield
–%
52W Range
1.30 - 4.85
% vs 50 MA
-9.50%
% vs 200 MA
4.37%
RSI-14
39.8
MACD Histogram
-0.0500
Beta (1Y vs SPY)
0.87
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
GlobeNewswire · Sep 10, 2026 12:00 PM
Chardan Initiates Adagene at Buy With $9 Price Target
MT Newswires · Sep 10, 2026 10:59 AM
Adagene Receives Milestone Payment From Exelixis
MT Newswires · Sep 9, 2026 1:42 PM
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
GlobeNewswire · Sep 9, 2026 12:00 PM
Adagene to Participate in Three Upcoming Investor Conferences
GlobeNewswire · Aug 20, 2026 12:00 PM
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
GlobeNewswire · Aug 12, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for ADAG.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.